The Asia Pacific Microwave Ablation Market should witness market growth of 14.9% CAGR during the forecast period (2022-2028).
Microwave ablation could be used laparoscopic, percutaneously, and open surgically either with ultrasound, CT, or with Fluoroscopy needle placement. This therapy was initially developed for the treatment of lung cancer which is now widely being used for treating liver tumors. Microwave ablation generates heat using electromagnetic waves, which develop a zone of energy that cause hyperthermic injury to tumor cells. Third-generation microwave ablation antennas are used in ablation zones that could be up to 6cm.
Various pre-clinical studies have been conducted to ensure the safety of the application of microwave energy for evaluating morphology, size & histologic features of ablation zone in different tissues and to analyze the effects of microwave ablation in different antenna patterns. In addition, other phase I clinical trials have also been conducted to ensure the effectiveness of microwave ablation for patients undergoing tumor ablation.
The continued technological advanced taking place have made tumor ablation treatment minimally invasive and safe. The rising awareness in the healthcare sector across the globe has resulted in the growing popularity of cancer ablation. Hospitals & healthcare centers have the potential of ablation technologies such as microwave ablation.
India is among the most populated nations across the globe. The Department of Economic & Social Affairs, United Nations, predicts that the proportion of Indians of age 60 and above will increase from 7.5% to 11% by 2025. As per the data on predicted demographic age structure, the nation had about 91.6 billion senior citizens in 2010, with an annual growth of about 2.5 million from 2005 to 2010. The senior population would continue to grow further in the upcoming years. Due to this, the demand for advanced minimally invasive therapies for the treatment is growing, thereby raising the demand for microwave ablation in the region.
The China market dominated the Asia Pacific Microwave Ablation Market by Country in 2021; thereby, achieving a market value of $55,977.7 Thousands by 2028. The Japan market is registering a CAGR of 14.2% during (2022-2028). Additionally, The India market would showcase a CAGR of 15.6% during (2022-2028).
Based on End-user, the market is segmented into Hospital, Research Laboratories, and Ambulatory Surgical Centers. Based on Component, the market is segmented into Accessories, Generator, and Power Distribution System. Based on Application, the market is segmented into Oncology, Cardiology, Urology, Orthopedic, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Varian Medical Systems, Inc. (Siemens Healthineers AG), AngioDynamics, Inc., Medtronic PLC, Johnson & Johnson (Johnson & Johnson Services, Inc.), Terumo Corporation, Emblation Limited, HUBER+SUHNER AG, MedWaves, Inc., SympleSurgical, Inc. and Mermaid Medical Group.
Microwave ablation could be used laparoscopic, percutaneously, and open surgically either with ultrasound, CT, or with Fluoroscopy needle placement. This therapy was initially developed for the treatment of lung cancer which is now widely being used for treating liver tumors. Microwave ablation generates heat using electromagnetic waves, which develop a zone of energy that cause hyperthermic injury to tumor cells. Third-generation microwave ablation antennas are used in ablation zones that could be up to 6cm.
Various pre-clinical studies have been conducted to ensure the safety of the application of microwave energy for evaluating morphology, size & histologic features of ablation zone in different tissues and to analyze the effects of microwave ablation in different antenna patterns. In addition, other phase I clinical trials have also been conducted to ensure the effectiveness of microwave ablation for patients undergoing tumor ablation.
The continued technological advanced taking place have made tumor ablation treatment minimally invasive and safe. The rising awareness in the healthcare sector across the globe has resulted in the growing popularity of cancer ablation. Hospitals & healthcare centers have the potential of ablation technologies such as microwave ablation.
India is among the most populated nations across the globe. The Department of Economic & Social Affairs, United Nations, predicts that the proportion of Indians of age 60 and above will increase from 7.5% to 11% by 2025. As per the data on predicted demographic age structure, the nation had about 91.6 billion senior citizens in 2010, with an annual growth of about 2.5 million from 2005 to 2010. The senior population would continue to grow further in the upcoming years. Due to this, the demand for advanced minimally invasive therapies for the treatment is growing, thereby raising the demand for microwave ablation in the region.
The China market dominated the Asia Pacific Microwave Ablation Market by Country in 2021; thereby, achieving a market value of $55,977.7 Thousands by 2028. The Japan market is registering a CAGR of 14.2% during (2022-2028). Additionally, The India market would showcase a CAGR of 15.6% during (2022-2028).
Based on End-user, the market is segmented into Hospital, Research Laboratories, and Ambulatory Surgical Centers. Based on Component, the market is segmented into Accessories, Generator, and Power Distribution System. Based on Application, the market is segmented into Oncology, Cardiology, Urology, Orthopedic, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Varian Medical Systems, Inc. (Siemens Healthineers AG), AngioDynamics, Inc., Medtronic PLC, Johnson & Johnson (Johnson & Johnson Services, Inc.), Terumo Corporation, Emblation Limited, HUBER+SUHNER AG, MedWaves, Inc., SympleSurgical, Inc. and Mermaid Medical Group.
Scope of the Study
By End-user
- Hospital
- Research Laboratories
- Ambulatory Surgical Centers
By Component
- Accessories
- Generator
- Power Distribution System
By Application
- Oncology
- Cardiology
- Urology
- Orthopedic
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Varian Medical Systems, Inc. (Siemens Healthineers AG)
- AngioDynamics, Inc.
- Medtronic PLC
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Terumo Corporation
- Emblation Limited
- HUBER+SUHNER AG
- MedWaves, Inc.
- SympleSurgical, Inc.
- Mermaid Medical Group
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Asia Pacific Microwave Ablation Market by End-user
Chapter 5. Asia Pacific Microwave Ablation Market by Component
Chapter 6. Asia Pacific Microwave Ablation Market by Application
Chapter 7. Asia Pacific Microwave Ablation Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Varian Medical Systems, Inc. (Siemens Healthineers AG)
- AngioDynamics, Inc.
- Medtronic PLC
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Terumo Corporation
- Emblation Limited
- HUBER+SUHNER AG
- MedWaves, Inc.
- SympleSurgical, Inc.
- Mermaid Medical Group
Methodology
LOADING...
